Quince Therapeutics Explores Strategic Alternatives After Clinical Setback
Following the failure of its lead clinical candidate, Quince Therapeutics has initiated a formal review of its strategic options. The...
Following the failure of its lead clinical candidate, Quince Therapeutics has initiated a formal review of its strategic options. The...
Volatus Aerospace has further solidified its position as a supplier within the NATO alliance, announcing the award of a new...
The biotechnology firm Enzo Biochem has completed its departure from public markets. The company's shares have been delisted following its...
Market participants are turning their focus to Rent the Runway as the company approaches a key financial reporting date. Following...
Metaplanet has issued a clarification regarding a recently announced financing round. The company's Chief Executive, Simon Gerovich, has publicly reaffirmed...
Shares of video game publisher Take-Two Interactive have faced considerable selling pressure recently, weighed down by sector-wide concerns and emerging...
As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a...
Investors in Truist Financial are shifting their focus toward shareholder returns as the company enters a period of consolidation following...
The market is applying fresh pressure to Microsoft's equity as investors recalibrate their expectations around the company's aggressive artificial intelligence...
India Globalization Capital (IGC Pharma) is significantly expanding the clinical development of its Alzheimer's drug candidate, IGC-AD1. The company has...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com